Functional MRI evidence of brain alterations in premenstrual dysphoric disorder: a systematic review - Report - MDSpire

Functional MRI evidence of brain alterations in premenstrual dysphoric disorder: a systematic review

  • By

  • Kornelia Bartoszewicz

  • Edyta Szurowska

  • June 4, 2026

  • 0 min

Share

Clinical Report: Neuroimaging Insights into Brain Changes Associated with PMDD

Overview

This comprehensive review analyzes functional brain alterations in women with Premenstrual Dysphoric Disorder (PMDD) using fMRI data from 598 participants. Key findings indicate significant changes in brain activation patterns, which may inform future therapeutic strategies.

Background

PMDD affects approximately 1.6% of women of reproductive age and is characterized by severe emotional and physical symptoms that significantly impair quality of life. Despite the availability of treatments, around 40% of women do not respond to first-line SSRIs, highlighting the need for a deeper understanding of its pathophysiology. Identifying brain function abnormalities could lead to novel interventions for PMDD.

Data Highlights

No numerical data presented in the source material.

Key Findings

  • Alterations in top-down regulatory mechanisms and large-scale brain networks were observed in PMDD patients.
  • Decreased activation was noted in the anterior cingulate cortex, dorsolateral prefrontal cortex, medial orbitofrontal cortex, and postcentral gyrus.
  • Increased activation was found in the amygdala and insula among PMDD patients.
  • Impairments in corticolimbic connectivity were identified, indicating widespread neural circuit involvement.
  • PMDD is driven by the brain's response to ovarian steroid fluctuations rather than abnormal peripheral hormone levels.

Clinical Implications

Understanding the neural circuits involved in PMDD may provide insights for developing targeted therapies. Clinicians should consider the complexity of PMDD when evaluating treatment options for affected patients.

Conclusion

The review underscores the multifaceted nature of PMDD, suggesting that future research should focus on the neural mechanisms involved to enhance treatment strategies.

Related Resources & Content

  1. BMC Psychiatry, 2025 -- Trait- versus state- grey matter volume alterations in premenstrual dysphoric disorder
  2. JAMA Network Open, 2025 -- Bidirectional Association Between Premenstrual Disorders and Psychiatric Disorders
  3. Frontiers in Neurology, 2026 -- Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine
  4. Conexiant, 2025 -- Premenstrual Disorders Linked to Broad Psychiatric Risk
  5. ACOG Clinical Practice Guideline No. 7, 2023 -- Management of Premenstrual Disorders
  6. ScienceDirect, 2025 -- Comparison of premenstrual dysphoric disorder treatment with antidepressants and combined oral contraceptives
  7. PMC, 2023 -- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
  8. ONG-23-1729 1516..1533
  9. Comparison of premenstrual dysphoric disorder treatment with antidepressants and combined oral contraceptives: a systematic review with network meta-analysis - ScienceDirect
  10. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder - PMC

Original Source(s)

Related Content